INVICTA logo

Invicta Diagnostic LTD

INVICTA·NSE·
69.95 -0.05 (-0.07%)
Market Cap88.00 Cr
PE Ratio17.89
Volume3,200
Day High - Low69.95 - 69.95
52W High-Low105.00 - 58.10
DocStoX Score
6.7/10
Fair
Fair Value
Sign in to see
ROE
14.70%
Average
P/E
17.89x
Fair
Debt / Equity
0.07
Low
Industry
Healthcare
Healthcare Service Provider
Overall View
Mixed

Price performance

52W58.10
105.00
DocStoX take

Supported by risk (8.5) and growth (8.2), but held back by momentum (1.5). Risk looks strong at 8.5, but that is offset by momentum at 1.5. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.7
/10
Fair
Quality
Solid
ROE 14.7%
Valuation
Fair
P/E 17.9×
Growth
Strong
Revenue +63.1% 3Y CAGR
Risk
Low risk
D/E 0.07
Momentum
Weak
25% of 52-week range

At a glance

Market Cap
₹88 Cr
52W High / Low
₹105 / ₹58
Dividend Yield
0.00%
Promoter Holding
66.70%
EPS (TTM)
₹3.91
Book Value
₹39.70

Key highlights

  • Revenue compounding 63% a year
  • Profit compounding 40% a year
  • Low leverage — D/E 0.07
  • Momentum is weak (1.5/10)
  • Small ₹88 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

INVICTA DIAGNOSTIC LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.